FARMACOLOGIA

cun id: 
745

Intermittent treatment (on/off treatment) with Tyrosine Kinase Inhibitors (TKIs) in pediatric CML patients with stable molecular response (ONOFF-PED CML 2019) A collaborative international IBFM- CML network group study

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma